RRC ID 65076
著者 Konishi Y, Ichise H, Watabe T, Oki C, Tsukiji S, Hamazaki Y, Murakawa Y, Takaori-Kondo A, Terai K, Matsuda M.
タイトル Intravital Imaging Identifies the VEGF-TXA2 Axis as a Critical Promoter of PGE2 Secretion from Tumor Cells and Immune Evasion.
ジャーナル Cancer Res
Abstract Prostaglandin E2 (PGE2) promotes tumor progression through evasion of anti-tumor immunity. In stark contrast to cyclooxygenase-dependent production of PGE2, little is known whether or not PGE2 secretion is regulated within tumor tissues. Here, we show that VEGF-dependent release of thromboxane A2 (TXA2) triggers Ca2+ transients in tumor cells, culminating in PGE2 secretion and subsequent immune evasion in the early stages of tumorigenesis. Ca2+ transients caused cPLA2 activation and triggered the arachidonic acid cascade. Ca2+ transients were monitored as the surrogate marker of PGE2 secretion. Intravital imaging of BrafV600E mouse melanoma cells revealed that the proportion of cells exhibiting Ca2+ transients is markedly higher in vivo than in vitro. The TXA2 receptor was indispensable for the Ca2+ transients in vivo, high intra-tumoral PGE2 concentration, and evasion of anti-tumor immunity. Notably, treatment with a vascular endothelial growth factor (VEGF) receptor antagonist and an anti-VEGF antibody rapidly suppressed Ca2+ transients and reduced TXA2 and PGE2 concentrations in tumor tissues. These results identify the VEGF-TXA2 axis as a critical promoter of PGE2-dependent tumor immune evasion, providing a molecular basis underlying the immunomodulatory effect of anti-VEGF therapies.
巻・号 81(15)
ページ 4124-4132
公開日 2021-8-1
DOI 10.1158/0008-5472.CAN-20-4245
PII 0008-5472.CAN-20-4245
PMID 34035084
MeSH Animals Dinoprostone / immunology* Humans Immune Evasion / immunology* Intravital Microscopy / methods* Mice Mice, Nude Vascular Endothelial Growth Factor A / immunology*
IF 9.727
リソース情報
ヒト・動物細胞 MDCK(RCB0995)